INTRODUCTION
Clinical and Economic Factors of Combination Therapy in Asthma
Slide Lecture
Activity Date: April 2002  — Activity Info: Volume 2, (S2)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

April 2002


Dear Colleague:

On behalf of The Johns Hopkins University School of Medicine, we are pleased to present you with this continuing education program titled "Clinical and Economic Factors of Combination Therapy in Asthma." This CD ROM Slide Lecture was developed to bring you new information about dual-controller therapy, the treatment strategy recommended by the National Heart, Lung, and Blood Institute for persistent asthma. The slide lecture is accompanied by expert commentary that will help you disseminate this information to other health care providers involved in the management of patients with asthma.

The CD ROM Slide Lecture considers the newest data on dual-controller therapy for asthma management in the context of the two primary sources of empirical evidence for evaluating pharmacotherapies-ie, randomized, controlled clinical trials and observational studies. The CD ROM Slide Lecture also reviews the complementary features of randomized, controlled clinical trials and observational studies and then considers the clinical trials-based and clinical practice-based data useful for choosing among dual-controller regimens. We hope that you find the information helpful in improving your ability to provide quality care to patients with asthma.


Sincerely,

Peter S. Creticos, MD
Johns Hopkins University School of Medicine
Clinical Director, Division of Allergy and Clinical Immunology
Medical Director, Asthma and Allergy Diseases
Johns Hopkins Asthma & Allergy Center

     
Home | Contact Us | View Account | Need Help?